Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0MQ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,336
Award facts
- Contract value 100% obligated
- $11,335.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,335.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections. The contract is firm fixed-price with no set-aside designation, indicating competitive award, and is scheduled for completion by February 5, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract valued at $999.999 billion with DLA Troop Support Medical through December 2031.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive pharmaceutical supply portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Zepbound, a semaglutide-based diabetes and weight management medication, aligns with the company's extensive experience delivering endocrinology products to federal agencies. The firm fixed-price structure and competitive award reflect AmerisourceBergen's demonstrated capability to meet federal procurement requirements for specialized pharmaceutical commodities through the DLA's primary pharmaceutical supply vehicle.
Quick answers
Who was awarded contract SPE2DR26F0MQ0?
SPE2DR26F0MQ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F0MQ0 worth?
The government has obligated $11,336 on SPE2DR26F0MQ0.
Is contract SPE2DR26F0MQ0 an order under another contract?
Yes. SPE2DR26F0MQ0 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0MQ0 competed?
The extent of competition for SPE2DR26F0MQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award